[EMA-decision on HES-restrictions].
Södersjukhu-set, Stockholm. christer.svensen@ki.se
Christer
C
Svensén
CLINTEC, ANOPIVA-kliniken, Karolinska universitetssjukhuset, Huddinge, båda Karolinska institutet.
Hans
H
Hjelmqvist
D004335:Drug and Narcotic Control; D005060:Europe; D017408:Guidelines as Topic; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects* / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000009:adverse effects* / Q000627:therapeutic use
D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes